GRAND RAPIDS, MICHIGAN–(Marketwired – June 1, 2017) –
Not for distribution to United States Newswire Services or for dissemination in the United States
Agility Health, Inc. (TSX VENTURE:AHI) (“Agility Health” or, the “Company“), a leading provider of rehabilitation services, orthotics and software services, today announced that, in accordance with the financial advisory agreement between the Company and Maxim Group LLC (“Maxim“) announced on January 31, 2017, Agility Health issued a total of 619,047 voting common shares to an affiliate of Maxim on June 1, 2017 in consideration for CAD$65,000 of services rendered by Maxim to the Company during the period from May 1, 2017 to May 31, 2017. The shares were issued at $0.105 per share, the closing price of the voting common shares on the TSX Venture Exchange on May 31, 2017, and are subject to a four-month hold period expiring October 2, 2017.
About Agility Health
Through its U.S. subsidiary and principal operating entity, Agility Health, LLC, Agility Health operates a multi-state network of outpatient rehabilitation clinics and provides contracted services to hospitals, nursing homes and other institutional clients, providing care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and a variety of other injuries and conditions. In addition, Agility Health provides a number of ancillary services related to physical rehabilitation, including practice management software systems and custom orthotics. As of January 1, 2017, Agility Health operates 84 outpatient or onsite rehabilitation locations in 14 states. Agility Health’s contract therapy services business provides rehabilitative services to 36 hospitals and inpatient rehabilitation units and 37 nursing homes, long-term care facilities and other service locations in 11 states.
In Canada, Medic Holdings Corp., Agility’s primary Canadian subsidiary, operates twelve (12) foot care clinics and manufactures orthotics and prosthetics.
For more information, please visit agilityhealth.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Wayne Cockburn
Vice President, Corporate Development
(905) 505-0770
[email protected]
www.agilityhealth.com
Ray Matthews
Ray Matthews and Associates
(604) 818-7778
[email protected]
